新冠后吉兰-巴雷综合征：来自阿曼的一例病例报告。
Post-COVID-19 Guillain-Barré Syndrome: A case report from Oman.
机构信息
Department of Psychiatry, Oman Medical Specialty Board, Muscat, Oman.
Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman.
出版信息
Sultan Qaboos Univ Med J. 2022 Aug;22(3):409-412. doi: 10.18295/squmj.6.2021.090. Epub 2022 Aug 25.
Guillain-Barré syndrome (GBS) has been reported as one of the neurological manifestations linked to COVID-19, a severe acute respiratory syndrome caused by coronavirus 2. We present the case of a 72-year-old male patient attending a tertiary care hospital in Muscat, Oman, in 2020 with a history of progressive bilateral limb weakness and numbness. The current diagnosis was in line with a rare complication of COVID-19. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. The patient received 0.4g/kg of intravenous immunoglobulin (IVIG) per day for five days. This case report highlights the characteristics and course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and course of various neuromuscular disorders in relation to COVID-19 infection.
格林-巴利综合征（GBS）已被报道为与 COVID-19 相关的一种神经系统表现之一，COVID-19 是由冠状病毒 2 引起的严重急性呼吸系统综合征。我们报告了 2020 年在阿曼马斯喀特的一家三级护理医院就诊的一位 72 岁男性患者的病例，该患者有进行性双侧肢体无力和麻木的病史。目前的诊断与 COVID-19 的一种罕见并发症一致。在排除其他可能的原因后，诊断为 COVID-19 引起的 GBS。患者每天接受 0.4g/kg 的静脉注射免疫球蛋白（IVIG），共五天。本病例报告强调了 COVID-19 感染后 GBS 的特征和病程。需要进一步的研究来描述与 COVID-19 感染相关的各种神经肌肉疾病的表现和病程。
Zotero 插件